Swiss-led research team uncovers key to treatment-resistant prostate cancer
An international research team led by the University of Bern has identified a key factor that causes some advanced prostate cancer to become resistant to hormonal therapy, unlocking new pathways to treatment.
This content was published on
2 minutes
UniB/jdp
Português
pt
Pesquisadores na Suíça descobrem chave para resistência a tratamento do câncer de próstata
The findings published in Nature CommunicationsExternal link shed light on “epigenetic” changes in cells that cause some aggressive forms of prostate cancer to become resistant to hormone therapy. These changes do not involve alterations of the DNA genetic code but often regulate gene activity and expression.
Prostate cancer is the second most common cancer and the fifth cause of cancer-related death in men worldwide. Most localized prostate cancer can be treated with surgery and radiotherapy, but metastatic cancer typically relies on hormone therapies. However, resistance to this therapy often develops.
To date, most studies on treatment resistance have focused on changes in the DNA sequence in cancer cells – genetic mutation. However, cancers can also become resistant to treatment through changes in cell identity. This “linear plasticity” helps them evade treatment.
As studies show that changes in the DNA are not sufficient to cause such a transformation in cell identity, a research team led Dr. Mark Rubin at the Bern Center for Precision Medicine sought to understand what other changes occur in cancer cells could enable this identity shift.
The research team found “epigenetic” changes could influence the way a cell uses the information contained in its DNA.
“Cancer cells can hijack this machinery to favor their growth over the surrounding normal cells,” explained Rubin in a statementExternal link.
The research team focused on one epigenetic regulator, called the SWI/SNF complex, which remodels a cell’s DNA and can cause the cells to grow and change. Dr. Rubin’s team observed that several prostate cancer cell lines are dependent on the SWI/SNF complex for their growth.
The Bern Center for Precision Medicine, a joint initiative between University of Bern and Insel Hospital, was launched in 2019 and explores precision medicine, especially in areas where there are no standard of care options.
Protein in abdominal fat could help shape obesity treatment
This content was published on
The study analysed fat cells from different locations in the body, and found that those in the abdomen have unique properties.
North African asylum claims fall after rapid Swiss processing
This content was published on
The accelerated procedure, now out of its test phase, has resulted in a significant drop in applications from North African countries.
This content was published on
The artist's song "The Code" focuses on their journey as a nonbinary individual. It is one of the favourites to win this year's contest.
Swiss climate activists block vehicles near Gotthard tunnel
This content was published on
Around ten climate activists briefly blocked the A2 motorway near the northern entrance of the Gotthard tunnel on Thursday.
Watches belonging to Michael Schumacher up for auction
This content was published on
Schumacher's family is auctioning off eight rare watches from his collection in Geneva. The Christie's auction will take place on Monday.
Joya Marleen and Baschi named best solo acts at Swiss Music Awards
This content was published on
St. Gallen singer Joya Marleen and Baschi from Basel were named artists of the year at the Swiss Music Awards 2024 on Wednesday night.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
Precision Medicine: A game changer for brain and mental health
This content was published on
Cancer patients benefit from precision medicine, but we must invest in a personalised approach to treating neurological disease such as Alzheimer’s.
The pharma holy grail: drugs for you, designed by you
This content was published on
In the age of sensors, wearables, and artificial intelligence (AI), almost everything can be customised for the individual.
Swiss cancer research yields breast-saving fat, better detection
This content was published on
The incidence of breast cancer in Switzerland is high, but research offers hope – especially the finding that cancer cells can be converted into fat.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.